Colgate-Palmolive (CL) has drawn fresh investor attention after reporting first quarter 2026 results that exceeded earnings expectations and reaffirming guidance for 2% to 6% net sales growth for the full year.

The stock has gained 5.09% on a 30 day share price return and 12.45% year to date, while the 1 year total shareholder return of a 1.39% decline suggests recent momentum contrasts with a softer longer term outcome.

If Colgate-Palmolive's move has you thinking about what else is working in the market, it may be worth scanning 19 top founder-led companies

With Colgate-Palmolive trading at $87.36 against a US$96 analyst target and a modelled intrinsic value gap of about 27%, you have to ask: is this a genuine value opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 9.6% Undervalued

Against Colgate-Palmolive's last close at $87.36, the most followed narrative points to a fair value of about $96.68, built on specific growth and margin assumptions.

Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally, supporting top-line organic sales acceleration and improved pricing power. Emerging markets such as India, Latin America, and Southeast Asia, where rising incomes and urbanization are growing the addressable customer base, remain a focus with stepped-up innovation, brand investment, and price tiering, sustaining long-term volume and revenue growth.

Curious what revenue runway, margin expansion, and future earnings multiple are baked into that fair value, and how a 6.98% discount rate ties it together? The full narrative lays out a detailed earnings and cash flow path that goes well beyond a simple price target headline.

Result: Fair Value of $96.68 (UNDERVALUED)

However, cautious consumer demand in key markets and higher raw material and packaging costs could still pressure volumes, margins, and the earnings path supporting that fair value.

Another View: Multiples Point To A Richer Price

While the SWS model suggests Colgate-Palmolive is 27.2% below its estimated future cash flow value, the P/E picture is less generous. At 33.5x earnings, the stock sits well above the global Household Products industry at 18x, peers at 21.3x, and a fair ratio of 23.6x, which implies meaningful valuation risk if sentiment cools.

That gap between cash flow value and rich earnings multiples leaves you with a clear question: is this a quality premium that holds, or a setup for a reset if growth or margins fall short? See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Unsure about the balance between value and risk so far? Take a moment to review the data, consider both the potential upside and concerns, and see the full breakdown of 3 key rewards and 3 important warning signs

Looking for more investment ideas?

If you stop at just one stock, you risk missing opportunities that better fit your goals, risk comfort, and income needs across different market conditions.

• Spot potential bargains before they are widely followed by checking companies highlighted in the screener containing 23 high quality undiscovered gems.
• Build a core of resilient holdings by focusing on companies featured in the solid balance sheet and fundamentals stocks screener (44 results).
• Strengthen your income stream by reviewing stocks included in the 12 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.